Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LESLEY K WHITE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1528374097
CMS profile
10932719
Location
LOUISVILLE, KY

General Payments · PY2021–2024

$2,211.50

  • Reported across 109 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$892.06

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $892.06 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
CSL Behring $257.13 11
Genentech USA, Inc. $162.52 3
Lilly USA, LLC $116.19 2
Amgen Inc. $84.21 5
GlaxoSmithKline, LLC. $61.65 4
Acerta Pharma LLC $58.39 4
ABBVIE INC. $58.21 3
Kaleo, Inc. $36.58 2
Octapharma USA, Inc. $28.69 1
Hikma Pharmaceuticals USA $14.72 1
OptiNose US, Inc. $13.77 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $239.29 16
PY2022 $289.01 17
PY2023 $791.14 39
PY2024 $892.06 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.26 01/02/2024 Food and Beverage Undisputed 01/23/2026 1108404132 CMS
ABBVIE INC. $13.72 03/19/2024 Food and Beverage Undisputed 01/23/2026 1108404134 CMS
ABBVIE INC. $25.23 05/28/2024 Food and Beverage Undisputed 01/23/2026 1108404136 CMS
Amgen Inc. $16.08 02/06/2024 Food and Beverage Undisputed 01/23/2026 1117413998 CMS
Amgen Inc. $18.60 06/27/2024 Food and Beverage Undisputed 01/23/2026 1117414000 CMS
Amgen Inc. $14.64 07/31/2024 Food and Beverage Undisputed 01/23/2026 1117414002 CMS
Amgen Inc. $18.43 08/29/2024 Food and Beverage Undisputed 01/23/2026 1117414004 CMS
Amgen Inc. $16.46 10/31/2024 Food and Beverage Undisputed 01/23/2026 1117414006 CMS
AstraZeneca Pharmaceuticals LP $14.43 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105857090 CMS
AstraZeneca Pharmaceuticals LP $15.14 04/22/2024 Food and Beverage Undisputed 01/23/2026 1105876971 CMS
AstraZeneca Pharmaceuticals LP $14.30 05/29/2024 Food and Beverage Undisputed 01/23/2026 1104665565 CMS
AstraZeneca Pharmaceuticals LP $14.52 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105784506 CMS
CSL Behring $33.71 01/24/2024 Food and Beverage Undisputed 01/23/2026 1134660223 CMS
CSL Behring $21.80 03/25/2024 Food and Beverage Undisputed 01/23/2026 1134660229 CMS
CSL Behring $17.55 06/03/2024 Food and Beverage Undisputed 01/23/2026 1134660243 CMS
CSL Behring $17.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 1134660245 CMS
CSL Behring $17.60 07/16/2024 Food and Beverage Undisputed 01/23/2026 1134660249 CMS
CSL Behring $20.38 08/12/2024 Food and Beverage Undisputed 01/23/2026 1134660251 CMS
CSL Behring $28.07 08/27/2024 Food and Beverage Undisputed 01/23/2026 1134660255 CMS
CSL Behring $27.66 10/22/2024 Food and Beverage Undisputed 01/23/2026 1134660271 CMS
CSL Behring $21.39 10/29/2024 Food and Beverage Undisputed 01/23/2026 1134660275 CMS
CSL Behring $21.93 11/18/2024 Food and Beverage Undisputed 01/23/2026 1134660283 CMS
CSL Behring $29.82 12/05/2024 Food and Beverage Undisputed 01/23/2026 1134660285 CMS
Genentech USA, Inc. $18.67 03/12/2024 Food and Beverage Undisputed 01/23/2026 1133170499 CMS
Genentech USA, Inc. $24.15 04/09/2024 Food and Beverage Undisputed 01/23/2026 1133170497 CMS
Genentech USA, Inc. $119.70 08/15/2024 Food and Beverage Undisputed 01/23/2026 1133170501 CMS
GlaxoSmithKline, LLC. $13.58 02/26/2024 Food and Beverage Undisputed 01/23/2026 1115740686 CMS
GlaxoSmithKline, LLC. $15.26 06/03/2024 Food and Beverage Undisputed 01/23/2026 1116093901 CMS
GlaxoSmithKline, LLC. $14.99 09/09/2024 Food and Beverage Undisputed 01/23/2026 1116530260 CMS
GlaxoSmithKline, LLC. $17.82 11/14/2024 Food and Beverage Undisputed 01/23/2026 1116660761 CMS
Hikma Pharmaceuticals USA $14.72 07/25/2024 Food and Beverage Undisputed 01/23/2026 1127504380 CMS
kaleo, Inc. $16.98 02/13/2024 Food and Beverage Undisputed 01/23/2026 1126633555 CMS
kaleo, Inc. $19.60 07/11/2024 Food and Beverage Undisputed 01/23/2026 1126633557 CMS
Lilly USA, LLC $16.30 11/04/2024 Food and Beverage Undisputed 01/23/2026 1135787812 CMS
Lilly USA, LLC $99.89 11/13/2024 Food and Beverage Undisputed 01/23/2026 1135796306 CMS
Octapharma USA, Inc. $28.69 09/19/2024 Food and Beverage Undisputed 01/23/2026 1142324028 CMS
Optinose US, Inc. $13.77 03/20/2024 Food and Beverage Undisputed 01/23/2026 1142177428 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.